Grace Therapeutics, Inc.
No enriched coverage for $GRCE in the last 7 days.
Opaleye Management Inc. purchased 87,801 indirectly-held shares of Grace Therapeutics, Inc. (GRCE) at an average of $1.81 ($1.77–$1.93, $0.16M total) across 2 trades over 2026-10-22 to 2026-10-26.
Insiders at Cytokinetics (CYTK), International Seaways (INSW), BJ’s (BJ), Grace (GRCE), and PBF (PBF) reported significant stock trades. Cytokinetics director sold 7,500 shares for $471,600. International Seaways shareholder sold 1.1M shares for $107.3M. BJ’s CEO sold 192,584 shares for $19.7M. Grace shareholder bought 85,697 shares for $165.6K. PBF Energy rep sold 170,000 shares for $14.96M.
Opaleye Management Inc. purchased 71,065 indirectly-held shares of Grace Therapeutics, Inc. (GRCE) at an average of $1.92 ($1.89–$1.95, $0.14M total) across 3 trades over 2026-10-14 to 2026-10-16.
Recent GRCE coverage spans insider activity, financial news and corporate actions.
In the last 30 days, GRCE insiders filed 13 SEC Form 4 transactions — 13 purchases ($473K) and no sales. The most active reporter was Opaleye Management Inc. with 13 filings.
Small insider purchase may signal modest confidence but unlikely to move price materially.
Strategic investor accumulation may support the stock.
The insider purchase signals confidence from a 10% owner, likely providing modest buying pressure.
A small insider purchase by a 10% owner adds modest buying pressure.
Small insider buy may provide modest support.
AlphAI scores every news story that mentions GRCE with an AI model for sentiment and relevance, and aggregates insider trades from Grace Therapeutics, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Opaleye Management Inc. purchased 87,801 indirectly-held shares of Grace Therapeutics, Inc. (GRCE) at an average of $1.81 ($1.77–$1.93, $0.16M total) across 2 trades over 2026-10-22 to 2026-10-26.
1 min readInsiders at Cytokinetics (CYTK), International Seaways (INSW), BJ’s (BJ), Grace (GRCE), and PBF (PBF) reported significant stock trades. Cytokinetics director sold 7,500 shares for $471,600. International Seaways shareholder sold 1.1M shares for $107.3M. BJ’s CEO sold 192,584 shares for $19.7M. Grace shareholder bought 85,697 shares for $165.6K. PBF Energy rep sold 170,000 shares for $14.96M.
1 min readOpaleye Management Inc. purchased 71,065 indirectly-held shares of Grace Therapeutics, Inc. (GRCE) at an average of $1.92 ($1.89–$1.95, $0.14M total) across 3 trades over 2026-10-14 to 2026-10-16.
1 min readOpaleye Management Inc. purchased 14,632 indirectly-held shares of Grace Therapeutics, Inc. (GRCE) at an average of $2.03 ($2.02–$2.04) across 3 trades over 2026-10-08 to 2026-10-12.
1 min readDivisadero Street Capital bought $2.17M of Lifeway Foods (LWAY) shares at $20.80-$21.09. Sonic Automotive (SAH) director Paul Rusnak acquired $1.66M in shares at $59.76. NexPoint Residential (NXRT) CIO Matt McGraner purchased $201K in stock. Grace Therapeutics (GRCE) saw $123.82K in insider buys. WILLAMETTE VALLEY VINEYARDS (WVVI) director increased holdings by $11.5K. GIC Private sold $721.6M in Medline (MDLN) shares. Apple (AAPL) exec Tim Cook sold $63.8M in stock.
3 min readOpaleye Management Inc. purchased 60,490 indirectly-held shares of Grace Therapeutics, Inc. (GRCE) at an average of $2.05 ($2.04–$2.07, $0.12M total) across 3 trades over 2026-10-01 to 2026-10-05.
1 min readOpaleye Management Inc. purchased 15,089 indirectly-held shares of Grace Therapeutics, Inc. (GRCE) at $2.10 across 2 trades over 2026-09-21 to 2026-09-23.
1 min readGrace Therapeutics, Inc. (GRCE) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On September 17, 2026, Grace Therapeutics, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Meeting”). Proxies for the Meeting were solicited pursuant to Section 14(a) of the Securities Exchange Act
1 min readOpaleye Management Inc. purchased 15,229 indirectly-held shares of Grace Therapeutics, Inc. (GRCE) at an average of $2.09 ($2.09–$2.10) across 2 trades over 2026-09-08 to 2026-09-09.
1 min readKohli Prashant (Chief Executive Officer) purchased 100,000 shares of Grace Therapeutics, Inc. (GRCE) at $2.14 ($0.21M total) on 2026-09-09.
1 min read